
|Articles|November 1, 2003
Prophylactic mitomycin-C limits haze, regression in PRK
Montreal-PRK using adjunctive intraoperative mitomycin-C (Mutamycin, Bristol-Myers Squibb) is a safe and effective tech- nique for treating eyes with high myopia, thin corneas, and large pupils, according to Pierre E. Demers, MD.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
TearSolutions advances Lacripep into phase 2 following dual FDA designations in neurotrophic keratitis
2
Oculis phase 3 DIAMOND trials miss vision endpoints in diabetic macular edema
3
Opuviz aflibercept biosimilar launches in Europe for retinal diseases
4
Study links alcohol consumption to earlier advanced presbyopia in men
5





















